Quality of optometry referrals to neovascular age-related macular degeneration clinic: a prospective study

JRSM Short Rep. 2011 Aug;2(8):64. doi: 10.1258/shorts.2011.011042. Epub 2011 Aug 1.

Abstract

Objectives: To evaluate the quality of referrals to a neovascular age-related macular degeneration clinic from optometrists using the standard Rapid Access Referral Form (RARF) from the Royal College of Ophthalmologists.

Design: A prospective study. Prospective data were gathered from all optometry referrals using the RARF, between the periods of December 2006 to August 2009. These were assessed for accuracy of history, clinical signs and final diagnosis as compared to a macula expert.

Setting: Highlands NHS Trust.

Participants: All patients referred to the eye department at NHS Highlands Trust using the RARF.

Main outcome measures: The symptoms of neovascular age-related macular degeneration correctly identified by optometrists, and the signs of neovascular age-related macular degeneration correctly identified by optometrists.

Results: Fifty-four RARFs were received during this period, there was an overall agreement with symptomatology in 57.4% of cases. Optometrists scored less well in recognizing the clinical signs of neovascular age-related macular degeneration, with the poorest scores for recognizing macular oedema (44.4%) and drusen (51.9%). Twenty (37%) patients referred had neovascular age-related macular degeneration.

Conclusions: RARFs make up the minority of referrals to the neovascular age-related macular degeneration clinic. Optometrists find it difficult to accurately elicit the signs of macula disease.